C. Mason

发表

11. IMMUNOMODULATION IN SEPSIS

G. Bagby, S. Nelson, C. Mason, 2001 .

Immunomodulation in Sepsis

G. Bagby, S. Nelson, C. Mason, 2001 .

Alcohol, tumor necrosis factor, and tuberculosis.

G. Bagby, S. Nelson, C. Mason, 1995, Alcoholism, clinical and experimental research.

Pathophysiology of pulmonary defense mechanisms

S. Nelson, C. Mason, W. Summer, 1992 .

The Nurse Practitioner's Role in Helping Patients Achieve Lipid Goals with Statin Therapy

C. Mason, 2005, Journal of the American Academy of Nurse Practitioners.

Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus.

J. Kolls, S. Nelson, C. Mason, 1995, The Journal of infectious diseases.

Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.

J. Shellito, C. Mason, L. Quinton, 2005, Tuberculosis.

in BAL fluid after ANTU-induced edema in rats Fluorescein-labeled dextran concentration is increased

P. Auberger, P. Hruz, M. Halford, 2015 .

Cimetidine does not impair pulmonary clearance ofPseudomonas aeruginosa in normal rats

E. Daon, C. Mason, W. Summer, 1994, Digestive Diseases and Sciences.

Development and Management of a Lipid Clinic

C. Mason, 2007 .

Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.

C. Mason, J. Ali, F. Lopez, 2008, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

Use of mefloquine in multidrug-resistant Mycobacterium avium complex pulmonary disease in an HIV-negative patient.

C. Mason, J. Ali, J. Ramirez, 2007, Current therapeutic research, clinical and experimental.

Immunity against mycobacteria.

C. Mason, J. Ali, 2004, Seminars in respiratory and critical care medicine.

Host defense in respiratory infections.

D. Welsh, C. Mason, 2001, The Medical clinics of North America.

Pulmonary host defenses. Implications for therapy.

C. Mason, S. Nelson, Steve Nelson, 1999, Clinics in chest medicine.

The effects of alcohol on immunity and bacterial infection in the lung.

C. Mason, S. Nelson, L. Gamble, 2006, Medecine et maladies infectieuses.

Venous Thromboembolism: A Chronic Illness

C. Mason, 2009, The Journal of cardiovascular nursing.

Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease.

C. Mason, A. Bank, D. Kaiser, 2004, Journal of the American College of Cardiology.

BACTERIAL COLONIZATION

C. Mason, W. Summer, S. Nelson, 1993, Immunology and Allergy Clinics of North America.

Keratinocyte growth factor increases transalveolar sodium reabsorption in normal and injured rat lungs.

B. Guery, C. Mason, W. Summer, 1997, American journal of respiratory and critical care medicine.

Effect of granulocyte colony-stimulating factor on acute lung injury in the rat.

C. Mason, W. Summer, D. Mercante, 1995, American journal of respiratory and critical care medicine.

CD4+ lymphocyte responses to pulmonary infection with Mycobacterium tuberculosis in naïve and vaccinated BALB/c mice.

J. Shellito, C. Mason, J. Shellito, 2001, Tuberculosis.

Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury.

J. Pittet, B. Guery, C. Mason, 2000, American journal of physiology. Lung cellular and molecular physiology.

Keratinocyte growth factor prevents ventilator-induced lung injury in an ex vivo rat model.

D. Welsh, C. Mason, W. Summer, 2000, American journal of respiratory and critical care medicine.

Pulmonary stress injury within physiological ranges of airway and vascular pressures.

B. Guery, C. Mason, W. Summer, 1998, Journal of critical care.

Pulmonary host defenses and factors predisposing to lung infection.

C. Mason, S. Nelson, 2005, Clinics in chest medicine.

Pulmonary Interleukin-23 Gene Delivery Increases Local T-Cell Immunity and Controls Growth of Mycobacterium tuberculosis in the Lungs

C. Mason, A. Ramsay, Anthony R. Odden, 2005, Infection and Immunity.

Fluorescein-labeled dextran concentration is increased in BAL fluid after ANTU-induced edema in rats.

B. Guery, C. Mason, W. Summer, 1998, Journal of applied physiology.

Ethanol and murine interleukin (IL)-12 production.

J. Kolls, C. Mason, E. Dobard, 2000, Alcoholism, clinical and experimental research.

Pathophysiology of pneumonia.

J. Kolls, C. Mason, W. Summer, 1995, Clinics in chest medicine.

Ventilation-Induced Lung Injury is Associated With an Increase in Gut Permeability

R. Neviere, D. Welsh, B. Guery, 2003, Shock.

The role of the inflammatory response in chronic bronchitis: therapeutic implications.

C. Mason, W. Summer, S. Nelson, 2000, Seminars in respiratory infections.

Keratinocyte growth factor attenuates hydrostatic pulmonary edema in an isolated, perfused rat lung model.

C. Creusy, D. Welsh, B. Guery, 2001, American journal of physiology. Heart and circulatory physiology.

Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms.

C. Mason, W. Summer, E. Dobard, 1997, The Journal of infectious diseases.

Comparative phenotypic characteristics of Staphylococcus aureus isolates from line and non-line associated septicaemia, CAPD peritonitis, bone/joint infections and healthy nasal carriers.

C. Mason, H. Tranter, S. J. Elvin, 1998, Journal of medical microbiology.

Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: A consensus statement

L. Mandell, R. Wunderink, G. Campbell, 1996 .

Fibronectin is not detectable on the intact buccal epithelial surface of normal rats or humans.

C. Mason, R. Bawdon, A. Pierce, 1990, American journal of respiratory cell and molecular biology.

Ethanol suppresses Mycobacteria tuberculosis-induced mRNA for nitric oxide synthase in alveolar macrophages, in vivo.

J. Kolls, C. Mason, J. Xie, 1995, Alcoholism, clinical and experimental research.

Decreased Expression of CD3ζ and Nuclear Transcription Factor κB in Patients with Pulmonary Tuberculosis: Potential Mechanisms and Reversibility with Treatment

C. Mason, A. Ochoa, A. Zea, 2006 .

Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment.

C. Mason, A. Ochoa, A. Zea, 2006, The Journal of infectious diseases.

Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.

G. Dai, J. Shellito, C. Mason, 2016, Vaccine.

Alcohol enhances type 1 interferon-α production and mortality in young mice infected with Mycobacterium tuberculosis

B. Samten, C. Mason, R. Vankayalapati, 2018, PLoS pathogens.

CD4+ CD25+ transforming growth factor‐β‐producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response *

C. Mason, P. Zhang, S. Nelson, 2007, Clinical and experimental immunology.

Thioguanine for refractory psoriasis: a 4-year experience.

G. Krueger, C. Mason, 2001, Journal of the American Academy of Dermatology.

Alcohol Exacerbates Murine Pulmonary Tuberculosis

C. Mason, Ping Zhang, E. Dobard, 2004, Infection and Immunity.

The impact of alcohol on BCG-induced immunity against Mycobacterium tuberculosis.

C. Mason, A. Ramsay, K. Happel, 2012, Alcoholism, clinical and experimental research.

Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia.

J. Shellito, S. Johnson, C. Mason, 1997, Respiratory medicine.

Niacin—A Critical Component to the Management of Atherosclerosis: Contemporary Management of Dyslipidemia to Prevent, Reduce, or Reverse Atherosclerotic Cardiovascular Disease

C. Mason, A. Doneen, 2012, The Journal of cardiovascular nursing.

Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model

C. Mason, 2009, Journal of the American Academy of Nurse Practitioners.

Prescription Omega-3s: An Overview for Nurse Practitioners

C. Mason, C. Conroy, Janet Long, 2011, The Journal of cardiovascular nursing.

Managing the spectrum of dyslipidemia in primary care.

C. Mason, 2003, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

Effect of alcohol on bacterial translocation in rats.

J. Kolls, C. Mason, E. Dobard, 1998, Alcoholism, clinical and experimental research.

Gastrointestinal gram-negative bacillary colonization accompanies oropharyngeal colonization but is not adversely affected by elevation of gastric pH

C. Mason, W. Summer, S. Kabir, 1992 .

Loss of compartmentalization of alveolar tumor necrosis factor after lung injury.

C. Mason, W. Summer, R. Beckerman, 1994, American journal of respiratory and critical care medicine.

Rapid Induction of mRNA for Nitric Oxide Synthase II in Rat Alveolar Macrophages by Intratracheal Administration of Mycobacterium Tuberculosis and Mycobacterium Avium

J. Kolls, C. Mason, P. Didier, 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Keratinocyte growth factor attenuates lung leak induced by alpha-naphthylthiourea in rats.

B. Guery, C. Mason, W. Summer, 1996, Critical care medicine.

DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection

C. Mason, A. Ramsay, W. Klimstra, 2015, PloS one.

Mediastinal pleomorphic sarcoma in an immunodeficient patient: case report and review of the literature.

J. Shellito, C. Mason, Farrukh Gill, 2012, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

Phagocytes in the pulmonary host defense system

C. Mason, Ping Zhang, S. Nelson, 2006 .

Immunity against mycobacteria.

C. Mason, J. Ali, 2004, Seminars in respiratory and critical care medicine.

Pathophysiology of Community-Acquired Pneumonia and Treatment Strategies Based on Host-Pathogen Interactions: The Inflammatory Interface

C. Mason, S. Nelson, 1996 .

Bacterial colonization: pathogenesis and clinical significance

C. Mason, W. Summer, S. Nelson, 1993 .

Normal host defenses and impairments associated with the delayed resolution of pneumonia.

C. Mason, S. Nelson, 1992, Seminars in respiratory infections.